Healthcare Equipment and Supplies
Company Overview of Panasonic Healthcare Co., Ltd.
Panasonic Healthcare Co., Ltd. engages in the provision of healthcare products. It offers biodiagnostic devices, including blood glucose monitoring systems, lactate monitoring systems, lancet systems, and electrically-operated growth hormone injectors for individual families and medical organizations; medical imaging products comprising ultrasound diagnostic systems, ultrasound transducers, pain relief lasers, and diode laser systems; and medical instruments and hospital systems, such as medication picking robot systems, in-hospital navigation systems for outpatients, and LCD monitors. The company also provides dental clinic/laboratory products that include primary processing for dental pros...
Nishi-shinbashi MF Building
Founded in 1948
Key Executives for Panasonic Healthcare Co., Ltd.
Panasonic Healthcare Co., Ltd. does not have any Key Executives recorded.
Panasonic Healthcare Co., Ltd. Key Developments
Sinocare Interested In Diabetes Devices Business from Bayer
May 20 15
Sinocare Inc. (SZSE:300298) intends to submit bid to acquire diabetes device business from Bayer AG (DB:BAYN), reported Bloomberg, citing people familiar with the matter. According to the reports, Sinocare made an offer of about $1 billion with Gold Stone Investment Co., Ltd., the direct-investment unit of CITIC Securities Company Ltd. Sinocare has reached out to Chinese banks to seek financing for a potential deal. Sinocare is competing with Panasonic Healthcare Co., Ltd., backed by KKR & Co. L.P. (NYSE:KKR), which has been holding talks to buy the Bayer unit from February 2015, the sources said.
Bayer Reportedly In Talks To Sell Diabetes Devices Division To Panasonic
Feb 20 15
Bayer AG (DB:BAYN) in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters. Bayer is making a second attempt to sell the Contour blood glucose-meter business. Panasonic Healthcare Co., Ltd. has been in talks with Bayer over the diabetes devices division for some time, but final bids are some weeks off, one source with direct knowledge of the matter said. Bloomberg reported that a sale to Panasonic, which could be valued at between €1 billion and €2 billion.
Panasonic Healthcare Reportedly Mulls Acquisition Of Diabetes Devices Business of Bayer
Feb 19 15
Panasonic Healthcare Co., Ltd. is reportedly seeking acquisition of diabetes devices business of Bayer AG. “Bayer AG is close to selling its diabetes devices business to Panasonic Healthcare Co., a joint venture backed by buyout firm KKR & Co.,” people with knowledge of the matter said. “An announcement on the sale may come as soon as today,” the people said, asking not to be identified as the information is private. “Talks are ongoing and an agreement may be delayed or fall apart, “they said. Representatives for Bayer and KKR declined to comment.
Similar Private Companies By Industry
Recent Private Companies Transactions